⌘K

Login Start Free

Home/Filings/4/0001209191-23-059032

4//SEC Filing

Dar Zavain 4

Accession 0001209191-23-059032

CIK 0001601830other

View on SEC.gov Company Profile

Filed

Dec 17, 7:00 PM ET

Accepted

Dec 18, 6:44 PM ET

Size

4.9 KB

Accession

0001209191-23-059032

Insider Transaction Report

Form 4

Period: 2023-12-14

RECURSION PHARMACEUTICALS, INC.RXRX

Director

Transactions

Sale
Class A Common Stock
2023-12-14$9.00/sh−20,141$181,269→ 53,823 total

Footnotes (1)

[F1]Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person on June 21, 2023

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

RECURSION PHARMACEUTICALS, INC.

CIK 0001601830

Entity typeother

Related Parties

1

filerCIK 0001852075

Filing Metadata

Form type: 4
Filed: Dec 17, 7:00 PM ET
Accepted: Dec 18, 6:44 PM ET
Size: 4.9 KB

View on SEC.gov